Polystyrene sulfonate

Analysis Note Assay (ionoc exchange): 38.0 - 42.

Application Biocompatible and biodegradable polymer. Can be used in the formation of nanoparticles for drug delivery.

Cyrene &#8482 2-Methyltetrahydrofuran Blend with BHT as an inhibitor is specially formulated for use in automated processes and applications where lower viscosity is required, making it easier to handle while maintaining high yields. This Cyrene

Cyrene &#8482 2-Methyltetrahydrofuran Blend with BHT as an inhibitor is specially formulated for use in automated processes and applications where lower viscosity is required, making it easier to handle while maintaining high yields. This Cyrene

Dimethylethylammoniumpropane sulfonate is a zwitterionic solubilizing agent with usefulness in protein crystallization. Application Dimethylethylammoniumpropane sulfonate has been used in a study to assess the functional properties of the separate

Application Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly( D , L -lactide) (PLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation

Application Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly( D , L -lactide) (PLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation

Application Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly( D , L -lactide) (PLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation

Application Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly( D , L -lactide) (PLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation

Application Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly( L -lactide) (PLLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation and

Application Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly( L -lactide) (PLLA) block. These materials have been used in control release and nanoparticle formulation for drug encapsulation and

Application Biocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic PCL block. These materials have been used as a block copolymer surfactant as well as in control release and nanoparticle formulation for